Royal Bank Of Canada Coh Bar, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.17 - $0.34 $3,145 - $6,290
-18,500 Reduced 94.52%
1,072 $0
Q1 2022

May 16, 2022
BUY
$0.25 - $0.43 $2,125 - $3,655
8,500 Added 76.77%
19,572 $6,000
Q4 2021

Feb 14, 2022
BUY
$0.34 - $1.0 $3,400 - $10,000
10,000 Added 932.84%
11,072 $4,000
Q3 2021

Nov 15, 2021
SELL
$0.96 - $1.62 $16,042 - $27,071
-16,711 Reduced 93.97%
1,072 $1,000
Q2 2021

Aug 16, 2021
BUY
$1.09 - $1.49 $19,383 - $26,496
17,783 New
17,783 $24,000

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0
View Full List

About CohBar, Inc.

CWBR Quotes by TradingView
  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.57M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email